Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose IV Vitamin C for Sepsis in Rwanda
NCT04088591Phase 3Withdrawn
- Sponsor
- Virginia Commonwealth University
- Start
- Oct 2022
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ascorbic acid in sepsis, sponsored by Virginia Commonwealth University. Planned start Oct 2022; status: withdrawn.
02
Drugs
ascorbic acid
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT04088591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04088591.